These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
24. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595 [TBL] [Abstract][Full Text] [Related]
25. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma. Wang XG; Zhu YW; Wang T; Chen B; Xing JC; Xiao W Kaohsiung J Med Sci; 2021 Mar; 37(3):192-199. PubMed ID: 33151036 [TBL] [Abstract][Full Text] [Related]
26. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling. Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521 [TBL] [Abstract][Full Text] [Related]
27. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis. Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539 [TBL] [Abstract][Full Text] [Related]
28. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling. Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852 [TBL] [Abstract][Full Text] [Related]
29. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma. Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976 [TBL] [Abstract][Full Text] [Related]
31. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594 [TBL] [Abstract][Full Text] [Related]
32. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782 [TBL] [Abstract][Full Text] [Related]
33. Decreased Expression of SATB2 Associates with Tumor Growth and Predicts Worse Outcome in Patients with Clear Cell Renal Cell Carcinoma. Sliwinska-Jewsiewicka A; Kowalczyk AE; Krazinski BE; Godlewski J; Kwiatkowski P; Kiewisz J; Grzegrzolka J; Dziegiel P; Kmiec Z Anticancer Res; 2018 Feb; 38(2):839-846. PubMed ID: 29374710 [TBL] [Abstract][Full Text] [Related]
34. Circular RNA hsa_circ_001895 serves as a sponge of microRNA-296-5p to promote clear cell renal cell carcinoma progression by regulating SOX12. Chen Z; Xiao K; Chen S; Huang Z; Ye Y; Chen T Cancer Sci; 2020 Feb; 111(2):713-726. PubMed ID: 31782868 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593 [TBL] [Abstract][Full Text] [Related]
37. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
38. The miR-200 family as prognostic markers in clear cell renal cell carcinoma. Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993 [TBL] [Abstract][Full Text] [Related]
39. PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival. Högner A; Krause H; Jandrig B; Kasim M; Fuller TF; Schostak M; Erbersdobler A; Patzak A; Kilic E Urol Oncol; 2018 Mar; 36(3):94.e1-94.e14. PubMed ID: 29169846 [TBL] [Abstract][Full Text] [Related]
40. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p. Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]